FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axis.
Ann Transl Med
; 9(3): 258, 2021 Feb.
Article
in En
| MEDLINE
| ID: mdl-33708885
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Ann Transl Med
Year:
2021
Document type:
Article